EMCURE PHARMACEUTICALS
Sector : Pharmaceuticals and health care | Midcap | BSE
Here's the live share price of Emcure Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-2.41₹ -37.55
As on Jan 23, 2026, 4:01 PM IST
Emcure Pharmaceuticals Price Performance
Today's LowToday's High
₹1,427.40₹1,562.25
₹1,520.95
52 Weeks' Low52 Weeks' High
₹890.00₹1,585.50
₹1,520.95
Open Price
₹1,558.60
Prev. Close
₹1,558.50
Volume
10,436
Over the last 5 years, the share price of Emcure Pharmaceuticals has gained 2.28% CAGR. Over the past year, the corresponding return has been 12.22%.
Emcure Pharmaceuticals’s current P/E of 36.36x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Emcure Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Emcure Pharmaceuticals | -2.44 | 6.68 | 9.95 | 6.70 | 12.22 | 3.83 | 2.28 |
| Sun Pharmaceutical Industries | -2.25 | -7.04 | -3.40 | -3.03 | -11.04 | 15.85 | 22.71 |
| Divi's Laboratories | -3.58 | -7.15 | -8.39 | -9.66 | 2.81 | 21.09 | 10.98 |
| Torrent Pharmaceuticals | -2.18 | 2.94 | 8.68 | 10.61 | 20.36 | 35.04 | 24.43 |
| Cipla | -5.94 | -12.37 | -20.08 | -10.76 | -9.39 | 7.36 | 9.45 |
| Dr. Reddy's Laboratories | 5.07 | -3.73 | -3.49 | -0.99 | -4.20 | 12.49 | 3.98 |
| Lupin | -1.80 | 1.13 | 10.16 | 11.28 | -0.61 | 40.80 | 14.59 |
| Zydus Lifesciences | 1.98 | -4.64 | -12.18 | -8.03 | -10.50 | 25.87 | 13.65 |
| Mankind Pharma | -3.37 | -5.72 | -14.15 | -19.15 | -20.13 | 13.87 | 8.11 |
| Alkem Laboratories | -1.53 | 2.72 | 3.90 | 15.48 | 10.94 | 23.61 | 13.06 |
| Aurobindo Pharma | -3.34 | -6.87 | 3.11 | 1.45 | -9.01 | 36.48 | 2.57 |
| Biocon | -2.62 | -8.41 | 1.46 | -7.36 | -7.40 | 13.96 | -0.80 |
| Abbott India | 0.62 | -1.38 | -7.14 | -19.56 | 0.40 | 8.57 | 13.97 |
| Glenmark Pharmaceuticals | -1.33 | -3.55 | 6.71 | -7.70 | 30.53 | 67.68 | 32.07 |
| Laurus Labs | -5.50 | -4.79 | 8.58 | 23.70 | 73.89 | 42.94 | 21.81 |
| GlaxoSmithKline Pharmaceuticals | -1.72 | -7.61 | -16.35 | -26.26 | 10.33 | 21.80 | 9.17 |
| Ipca Laboratories | -3.08 | 2.03 | 14.81 | 0.03 | -7.56 | 18.79 | 8.11 |
| Anthem Biosciences | -1.94 | -9.79 | -15.97 | -20.07 | -17.35 | -6.16 | -3.74 |
| Ajanta Pharma | 0.73 | 1.26 | 11.74 | -0.62 | -6.52 | 31.14 | 18.30 |
| J B Chemicals & Pharmaceuticals | -4.03 | 1.17 | 6.92 | 8.05 | 1.11 | 22.79 | 28.39 |
Over the last one year, Emcure Pharmaceuticals has gained 12.22% compared to peers like Sun Pharmaceutical Industries (-11.04%), Divi's Laboratories (2.81%), Torrent Pharmaceuticals (20.36%). From a 5 year perspective, Emcure Pharmaceuticals has underperformed peers relative to Sun Pharmaceutical Industries (22.71%) and Divi's Laboratories (10.98%).
Emcure Pharmaceuticals Financials
Emcure Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,553.47 | 1,550.99 |
| 10 | 1,538.25 | 1,536.58 |
| 20 | 1,475.83 | 1,504.18 |
| 50 | 1,425.49 | 1,450.44 |
| 100 | 1,391.45 | 1,408.44 |
| 200 | 1,321.26 | 1,372.16 |
Emcure Pharmaceuticals Share Holding Pattern
In the latest quarter, Emcure Pharmaceuticals remained same as its previous close in promoter holding, while DII stake increased to 6.10%, FII holding rose to 3.59%, and public shareholding moved down to 12.43% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Emcure Pharmaceuticals Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 20,31,343 | 0.55 | 277.18 | |
| 13,49,941 | 1.19 | 184.2 | |
| 7,46,337 | 1.23 | 101.84 | |
| 6,23,160 | 0.56 | 85.03 | |
| 5,70,564 | 0.49 | 77.85 | |
| 4,87,649 | 0.55 | 66.54 | |
| 4,39,742 | 0.9 | 60 | |
| 3,88,087 | 1.7 | 52.95 | |
| 2,96,035 | 0.55 | 40.39 | |
| 2,95,129 | 0.21 | 40.27 |
* Excluding Index & Arbitrage Funds
Emcure Pharmaceuticals Corporate Actions
Date Time | Announcement |
|---|---|
| Jan 22, 2026, 9:50 PM IST | Emcure Pharmaceutica - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Jan 22, 2026, 9:35 PM IST | Emcure Pharmaceutica - Board Meeting Intimation for Board Meeting Intimation For Approval Of Unaudited Financial Results (Sta |
| Jan 07, 2026, 6:55 PM IST | Emcure Pharmaceutica - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Dec 23, 2025, 11:41 PM IST | Emcure Pharmaceutica - Update On US FDA Inspection At Our Manufacturing Facility Located At Kadu, Surendranagar, Gujarat, Ind |
| Dec 22, 2025, 5:11 PM IST | Emcure Pharmaceutica - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
About Emcure Pharmaceuticals
Emcure Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 16/04/1981 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24231PN1981PLC024251 and registration number is 024251. Currently Company is involved in the business activities of Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 4381.92 Cr. and Equity Capital is Rs. 189.48 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressPlot No. P-1 & P-2, IT-BT Park, Phase II, Pune Maharashtra 411057
- Contact
Management
- Mr. Berjis Minoo DesaiChairman & Non-Exe.Director
- Mr. Satish Ramanlal MehtaManaging Director & CEO
- Mr. Sunil Rajanikant MehtaWhole Time Director
- Ms. Namita Vikas ThaparWhole Time Director
- Mr. Samit Satish MehtaWhole Time Director
- Dr. Mukund Keshao GurjarWhole Time Director
- Mr. Vijay Keshav GokhaleIndependent Director
- Mr. Palamadai Sundararajan JayakumarIndependent Director
- Dr. Vidya Rajiv YeravdekarIndependent Director
- Dr. Shailesh Kripalu AyyangarIndependent Director
FAQs on Emcure Pharmaceuticals Share Price
What is the share price of Emcure Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Emcure Pharmaceuticals is ₹1,520.95 as on Jan 23, 2026.
What kind of stock is Emcure Pharmaceuticals?
The Emcure Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Midcap stock on the BSE.
What is the Market Cap of Emcure Pharmaceuticals?
The market cap of Emcure Pharmaceuticals is ₹28,833.04 Cr as on Jan 23, 2026.
What are today's High and Low prices of Emcure Pharmaceuticals?
Today’s highest and lowest price of Emcure Pharmaceuticals are ₹1,562.25 and ₹1,427.40.
What are the 52 Week High and 52 Week Low of Emcure Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which Emcure Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Emcure Pharmaceuticals is ₹1,585.50 and 52-week low of Emcure Pharmaceuticals is ₹890.00 as on Jan 23, 2026.
How has the Emcure Pharmaceuticals performed historically in terms of returns?
The Emcure Pharmaceuticals has shown returns of -2.41% over the past day, 6.68% for the past month, 9.95% over 3 months, 12.22% over 1 year, 3.83% across 3 years, and 2.28% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Emcure Pharmaceuticals?
P/E ratio of and PB ratio of Emcure Pharmaceuticals are 36.36 and 6.08 on Jan 23, 2026. While the company gives a dividend yield of 0.20 per annum.
✕
Market Pulse